NCT07179354

Brief Summary

This clinical trial compares three different treatment methods used to correct jaw problems in children with Class III malocclusion (a condition where the lower jaw is positioned forward relative to the upper jaw). The treatments include: Rapid maxillary expansion with face mask (RME/FM), Mini maxillary protractor (MMP), Modified splints with elastics and chin cup (SEC III). The study aims to understand how each treatment affects the bones and soft tissues of the face, such as how much the upper jaw moves forward or the lower jaw moves backward, as well as changes in teeth alignment and facial appearance. Results showed that different treatments work best for different aspects: some are better for moving the upper jaw forward, while others are better for repositioning the lower jaw. This information helps doctors choose the most suitable treatment plan for each patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

September 11, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Class III malocclusionRME/FMMini maxillary protractorSEC III3D stereophotogrammetrySoft tissueCephalometry

Outcome Measures

Primary Outcomes (1)

  • Three-dimensional changes in soft tissues

    3D stereophotogrammetry used to assess overall soft tissue profile changes, including facial convexity and lip-chin parameters.

    baseline to post-treatment (≈ 9 months)

Secondary Outcomes (1)

  • Two dimensional changes in skeletal parameters of the maxilla and mandible

    Baseline (pre-treatment) to post-treatment (≈ 9 months)

Study Arms (4)

RME/FM Group (Rapid Maxillary Expansion with Face Mask)

EXPERIMENTAL

Participants in this group received rapid maxillary expansion using a bonded expander, followed by protraction with a face mask. This protocol aims to advance the maxilla in patients with Class III skeletal malocclusion.

Device: Rapid Maxillary Expansion with Face Mask (RME/FM)

MMP Group (Mini Maxillary Protractor)

EXPERIMENTAL

This group was treated with the Mini Maxillary Protractor (MMP), a custom-designed intraoral appliance used to achieve orthopedic maxillary protraction without external devices. The aim is to promote maxillary advancement in growing Class III patients.

Device: Mini Maxillary Protractor (MMP)

Modified SEC III Group (Modified Splints with Elastics and Chin Cup)

EXPERIMENTAL

Participants in this group were treated using modified splints with intermaxillary elastics and a chin cup (SEC III protocol). The protocol is designed to restrict mandibular growth and enhance maxillary positioning in patients with skeletal Class III malocclusion.

Device: Modified Splint with Elastics and Chin Cup (Modified SEC III)

Control Group (Untreated group selected from archival records)

NO INTERVENTION

This group includes untreated patients with Class III skeletal malocclusion, selected from archival records. No intervention was administered. The group serves as a baseline comparison for evaluating treatment effects.

Interventions

A tooth- and tissue-borne rapid maxillary expansion appliance with an expansion screw was used to achieve transverse maxillary expansion, followed by Petit-type face mask therapy. Expansion protocol: two quarter-turns per day for 10-14 days, then one quarter-turn per day until cusp-to-cusp relationship was achieved. Face mask elastics applied 16 hours/day at 350-500 g per side, with a 30° downward and forward vector relative to the occlusal plane.

RME/FM Group (Rapid Maxillary Expansion with Face Mask)

An intraoral mini maxillary protraction appliance was used to advance the maxilla. Force was applied through intraoral elastics connected to intraoral anchorage units. The protocol was designed to deliver orthopedic forward traction of the maxilla without an external face mask.

MMP Group (Mini Maxillary Protractor)

A modified splint appliance combined with intraoral elastics and an orthopedic chin cup was used to achieve skeletal mandibular retrusion and Class III correction. The appliance applied orthopedic forces through combined vertical and horizontal components, promoting backward positioning of the mandible while maintaining transverse maxillary relationships.

Modified SEC III Group (Modified Splints with Elastics and Chin Cup)

Eligibility Criteria

Age9 Months - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Individuals who have not completed their growth spurt (9-12 years old)
  • Overjet ≤ 0 mm (patients with negative overjet must be De Nevreze positive)
  • ANB ≤ 0°, Witts \< 1
  • Good oral hygiene and healthy periodontal tissues
  • SN-GoGn angle between 26° and 38°
  • No congenital or acquired tooth loss (excluding third molars)
  • Body mass index (BMI) between 18-26 kg/m²
  • No systemic, local, or endocrinological diseases

You may not qualify if:

  • Presence of any syndrome or developmental deformity
  • Previous orthodontic treatment
  • Allergy to any metal or acrylic
  • Presence of any systemic disease affecting treatment
  • SN-GoGn angle \> 38°
  • Presence of temporomandibular joint disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University, Faculty of Dentistry, Department of Orthodontics

Kayseri, 38039, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Malocclusion, Angle Class III

Interventions

Masks

Condition Hierarchy (Ancestors)

MalocclusionTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Gökhan Çoban, Associate Professor, PhD,

    Erciyes University, Faculty of Dentistry, Department of Orhodontics

    PRINCIPAL INVESTIGATOR
  • Tuba Ünlü Çiftçi, Research Assistant

    Erciyes University, Faculty of Dentistry, Department of Orhodontics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study uses a parallel assignment design, where participants with Class III skeletal malocclusion are randomly assigned to one of three treatment groups: rapid maxillary expansion with face mask (RME/FM), mini maxillary protractor (MMP), or modified splints with elastics and chin cup (SEC III). Additionally, a control group consisting of untreated patients with similar malocclusion characteristics from archival records is included for comparison. Each treatment group receives its specific intervention simultaneously, and outcomes are compared among all groups to evaluate the efficacy of each protocol.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 17, 2025

Study Start

February 21, 2024

Primary Completion

January 9, 2025

Study Completion

March 3, 2025

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the dataset is limited to a small number of pediatric patients and was collected solely for internal academic research purposes.

Locations